A Relative Bioavailability Study of HRS9531 in Healthy Subjects

NCT05893576 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: HRS9531
DRUG: HRS9531

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.